Word

BUNGEMAXX

Status

Registered

Status Code

700

Status Date

Tuesday, November 26, 2019

Serial Number

79251213

Registration Number

5917307

Registration Date

Tuesday, November 26, 2019

Mark Type

4000

Filing Date

Thursday, November 22, 2018

Published for Opposition

Tuesday, September 10, 2019

Trademark Owner History

BUNGE SA -
BUNGE LIMITED - Original Registrant

Classifications

29 Processed food preparations and dishes made with meat, fish, poultry, game, meat extracts, preserved, frozen, dried and cooked fruits and vegetables, jellies, jams, compotes, eggs, milk and milk products, edible oils and fats, and also containing natural components, antioxidants, carotenoids or other natural components, ascorbic acid, tocopherols, lecithin, vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids, not for medical use; lecithin for culinary use

5 Medicinal preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; pharmaceutical preparations for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; nutraceutical preparations for therapeutic or medical use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; dietetic foods for medical use; antioxidants for medical use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; food supplements; antioxidants used as food supplements; adjuvants for medical use; lecithin for pharmaceutical use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; vitamin preparations; preparations for medical use containing vitamins, trace elements, fatty acids, amino acids, enzymes and coenzymes, or plant extracts for medicinal use for management of gallstones, management of liver disorders, management of neurological disorders, improving memory, improving attention, improving cognitive decline, modulation of mood and stress, management of heart-related conditions, management of cholesterol levels, management of atherosclerosis and heart disease; food supplements of proteins, carbohydrates, ores, lipids, sterol or other nutrients including ascorbic acid, tocopherols, lecithin, vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids

1 Chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of food; antioxidants for the manufacture of cosmetics; vitamins for the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; antioxidants for the manufacture of food supplements; proteins for the manufacture of food supplements; vitamins for the manufacture of food supplements; proteins for the food industry; vitamins for the food industry; chemical preparations for preserving foodstuffs; chemical additives for oils; oils for the preservation of food; vitamins for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry; raw material, namely, lecithin for use in the manufacture of food products; lecithin for industrial purposes; lecithin for the food industry; chemical additives for the manufacture of food and beverages based on ascorbic acid, carbohydrate, tocopherols, lecithin, vitamin E, sterols and ester sterols, glycerin, proteins, tocotrienols, squalene, carotenoids; antioxidants for the manufacture of pharmaceutical products

BUNGE MAX

Trademark Events

Apr 5, 2024

Change Of Owner Received From Ib

May 4, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

May 4, 2023

Teas Change Of Correspondence Received

May 4, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

May 4, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

May 4, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 4, 2023

Teas Change Of Owner Address Received

Nov 27, 2020

New Representative At Ib Received

Nov 27, 2020

Change Of Name/Address Rec'd From Ib

Apr 3, 2020

Final Decision Transaction Processed By Ib

Mar 18, 2020

Final Disposition Notice Sent To Ib

Mar 18, 2020

Final Disposition Processed

Feb 26, 2020

Final Disposition Notice Created, To Be Sent To Ib

Nov 26, 2019

Registered-Principal Register

Sep 10, 2019

Official Gazette Publication Confirmation E-Mailed

Sep 10, 2019

Published For Opposition

Aug 21, 2019

Notification Of Notice Of Publication E-Mailed

Aug 8, 2019

Assigned To Lie

Jul 29, 2019

Approved For Pub - Principal Register

Jul 29, 2019

Examiner's Amendment Entered

Jul 29, 2019

Notification Of Examiners Amendment E-Mailed

Jul 29, 2019

Examiners Amendment E-Mailed

Jul 29, 2019

Examiners Amendment -Written

Jul 26, 2019

Teas/Email Correspondence Entered

Jul 25, 2019

Correspondence Received In Law Office

Jul 25, 2019

Teas Response To Office Action Received

Mar 29, 2019

Refusal Processed By Ib

Mar 15, 2019

Change Of Owner Received From Ib

Mar 9, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Mar 9, 2019

Refusal Processed By Mpu

Mar 1, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Feb 28, 2019

Non-Final Action Written

Feb 25, 2019

Assigned To Examiner

Feb 15, 2019

Application Filing Receipt Mailed

Feb 11, 2019

New Application Office Supplied Data Entered

Feb 7, 2019

Sn Assigned For Sect 66a Appl From Ib